Vyne Therapeutics Inc. · NASDAQ:VYNE
Eventide Asset Management, LLC reported a 9.99% stake in Vyne Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Eventide Asset Management, LLC reported a 9.99% stake in Vyne Therapeutics Inc., 1,849,597 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,849,597
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 9.99% | 1,849,597 |
| Finny Kuruvilla, M.D. Ph. D. | 9.99% | 1,849,597 |
| Robin C. John | 9.99% | 1,849,597 |
Source
Related
- Vyne Therapeutics Inc.
- Eventide Asset Management, LLC
- Vyne Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Nov 14, 2025
- Form 4 · Zeronda Tyler · Jul 24, 2026
- Form 4 · Stuart Iain · Jul 24, 2026
- Form 4 · Harsch Mutya · Jul 24, 2026
- Form 4 · Domzalski David · Jul 24, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 17, 2026